Literature DB >> 33283536

A Nomogram Combing Peripheral Parameters for Estimation of CRSwNP Recurrence.

Kun Du1, Ming Zheng1, Yan Zhao2, Chunyuan Jiao3, Wenbin Xu4, Yun Hao1, Yue Wang1, Jinming Zhao1, Xiangdong Wang1,2, Luo Zhang1,2,5,6.   

Abstract

BACKGROUND: The preoperative prediction of the recurrence of chronic rhinosinusitis with nasal polyps (CRSwNP) remains difficult in clinical practice.
OBJECTIVE: We aimed to develop a nomogram that combined peripheral risk factors to clinically predict the recurrence of CRSwNP.
METHODS: Data from 158 CRSwNP patients who underwent endoscopic sinus surgery (ESS) from January 2012 to December 2016 were collected, and the patients were followed up for 3 years. Of these, 96 patients who underwent ESS in an earlier period formed the training cohort for nomogram development, and 62 patients who underwent ESS thereafter formed the validation cohort to confirm the model's performance. Risk factors for recurrence identified by univariate and multivariate logistic regression were used to create a nomogram.
RESULTS: The recurrence rate was 29.2% (28/96) for the training cohort and 35.5% (22/62) for the validation cohort. Univariate analysis identified blood eosinophils (Eos), serum IgE level, asthma comorbidity, and the number of previous ESSs as risk factors for recurrence. Among those four parameters, serum IgE level and a previous ESS surgery were identified as two independent risk factors. A nomogram consisting of blood Eos, total serum IgE level, asthma comorbidity, and the number of previous ESSs was constructed, demonstrating a C index of 0.81 (95% CI, 0.79-0.83) and 0.80 (95% CI, 0.77-0.83) for predicting recurrence in the training and validation cohorts, respectively. The nomogram had well-fitted calibration curves.
CONCLUSION: The nomogram might be able to preoperatively predict the recurrence of CRSwNP by using currently available and objective parameters. Further studies are required to validate its reliability and effectiveness.

Entities:  

Keywords:  asthma; chronic rhinosinusitis; endoscopic sinus surgery; eosinophils; immunoglobulin E; nasal polyps; nomogram; prediction; prognosis; recurrence

Year:  2020        PMID: 33283536     DOI: 10.1177/1945892420978957

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  5 in total

1.  Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.

Authors:  Junqin Bai; Julia H Huang; Caroline P E Price; Jacob M Schauer; Lydia A Suh; Regan Harmon; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Anju T Peters; Whitney W Stevens; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2022-03-16       Impact factor: 14.290

2.  Involvement of the extracellular matrix proteins periostin and tenascin C in nasal polyp remodeling by regulating the expression of MMPs.

Authors:  Kun Du; Min Wang; Nan Zhang; Pei Yu; Ping Wang; Ying Li; Xiangdong Wang; Luo Zhang; Claus Bachert
Journal:  Clin Transl Allergy       Date:  2021-09-06       Impact factor: 5.657

3.  Elevated ALCAM Expression Associated with Endotypes and Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Hua Zhang; Shaobing Xie; Ruohao Fan; Fengjun Wang; Zhihai Xie; Weihong Jiang
Journal:  J Inflamm Res       Date:  2022-02-15

4.  Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Fang Zhang; Zhenhang Xu; Xi He; Yi Sun; Chong Zhao; Jianhui Zhang
Journal:  Mediators Inflamm       Date:  2022-04-08       Impact factor: 4.529

5.  Exploration of Predictive Biomarkers for Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps Based on Serum Multiple-Cytokine Profiling.

Authors:  Gang Wang; Huiyuan Zheng; Xiaoqian Chen; Jing Zheng; Jiabin Zhan; Rui Li; Yanyan Qi; Yi Ye; Min Zeng; Xin Wei
Journal:  Mediators Inflamm       Date:  2022-09-28       Impact factor: 4.529

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.